User contributions for Mastermindful
A user with 71 edits. Account created on 20 May 2015.
1 November 2016
- 13:0113:01, 1 November 2016 diff hist −26 m Roivant Sciences fixed typos, clarified language
17 October 2016
- 16:2416:24, 17 October 2016 diff hist −1 m Roivant Sciences fix commas
15 October 2016
- 00:0000:00, 15 October 2016 diff hist −1 Roivant Sciences No edit summary
10 July 2016
- 19:0519:05, 10 July 2016 diff hist +292 EHMT2 →Interactions: added content Tags: Mobile edit Mobile web edit
17 September 2015
- 21:1121:11, 17 September 2015 diff hist +12 m Catalyst Pharmaceuticals added hyperlinks
14 September 2015
- 20:4120:41, 14 September 2015 diff hist +2 Myasthenia gravis →Blood tests
- 20:4020:40, 14 September 2015 diff hist −3 Myasthenia gravis →Blood tests
- 15:5915:59, 14 September 2015 diff hist +1 m Catalyst Pharmaceuticals fixed reference formatting
8 September 2015
- 22:0522:05, 8 September 2015 diff hist +212 m Catalyst Pharmaceuticals Added Seeking Alpha reference
- 21:3121:31, 8 September 2015 diff hist +444 User talk:MelanieN →Restoring Catalyst Pharmaceuticals page
- 21:2221:22, 8 September 2015 diff hist +76 N User:Mastermindful ←Created page with 'Here is my user page. I'm interested in drug development for rare diseases.' current
- 21:1821:18, 8 September 2015 diff hist +23 Catalyst Pharmaceuticals No edit summary
- 21:1521:15, 8 September 2015 diff hist +321 Catalyst Pharmaceuticals No edit summary
- 20:5720:57, 8 September 2015 diff hist +749 Catalyst Pharmaceuticals No edit summary
- 18:5918:59, 8 September 2015 diff hist +825 Catalyst Pharmaceuticals No edit summary
4 September 2015
- 00:0600:06, 4 September 2015 diff hist +3,621 Catalyst Pharmaceuticals No edit summary
25 August 2015
- 16:0916:09, 25 August 2015 diff hist +71 User talk:MelanieN →Restoring Catalyst Pharmaceuticals page
- 16:0816:08, 25 August 2015 diff hist +338 User talk:MelanieN →Restoring Catalyst Pharmaceuticals page: new section
5 June 2015
- 18:0618:06, 5 June 2015 diff hist +1 m Amifampridine No edit summary
- 18:0618:06, 5 June 2015 diff hist +109 m Amifampridine →Uses: added 3,4-DAP mechanism reference
- 17:5417:54, 5 June 2015 diff hist 0 m Amifampridine fixed typos
- 17:5317:53, 5 June 2015 diff hist +4 m Amifampridine fixed typos
- 17:5317:53, 5 June 2015 diff hist +7 m Amifampridine fixed wording
- 17:5217:52, 5 June 2015 diff hist +167 m Amifampridine Added reference for the Jacobus AAN pre-trial study for the ongoing DAPPER clinical trial
28 May 2015
- 17:2417:24, 28 May 2015 diff hist +107 m Amifampridine →Cost: Added published clinical trial result reference
- 17:2017:20, 28 May 2015 diff hist +364 m Amifampridine →Cost: Added references that were removed and clarified current availability- marketing exclusivity 'pending FDA approval' would not impact availability from compassionate use
- 17:0617:06, 28 May 2015 diff hist 0 m Congenital myasthenic syndrome →Diagnosis and treatment: moved references to end of sentence
22 May 2015
- 19:4219:42, 22 May 2015 diff hist +172 m Wikipedia:Articles for deletion/Catalyst Pharmaceuticals No edit summary
- 18:4718:47, 22 May 2015 diff hist −1 m Catalyst Pharmaceuticals typo
- 18:4318:43, 22 May 2015 diff hist +4 m Neuromuscular junction →Congenital myasthenic syndromes
- 18:4118:41, 22 May 2015 diff hist +4 m Catalyst Pharmaceuticals No edit summary
- 18:3618:36, 22 May 2015 diff hist +26 m Catalyst Pharmaceuticals clarified reference
- 18:3518:35, 22 May 2015 diff hist +167 m Catalyst Pharmaceuticals added news article reference
- 18:3118:31, 22 May 2015 diff hist −1 m Congenital myasthenic syndrome →Diagnosis and treatment: typo
- 18:3018:30, 22 May 2015 diff hist +101 m Congenital myasthenic syndrome →Diagnosis and treatment: added FDA reference
- 18:2818:28, 22 May 2015 diff hist −1 m Congenital myasthenic syndrome →Diagnosis and treatment: fixed typo
- 18:2618:26, 22 May 2015 diff hist +1,582 m Congenital myasthenic syndrome →Diagnosis and treatment: added details of 3,4-DAP treatment
- 18:1818:18, 22 May 2015 diff hist +2 m Amifampridine No edit summary
- 18:1718:17, 22 May 2015 diff hist −4 m Amifampridine fixed language and typo
- 18:1318:13, 22 May 2015 diff hist −1 m MuSK protein →MuSK's role in disease: language clarification
- 18:1318:13, 22 May 2015 diff hist +509 m Myasthenia gravis →Research directions: added preclinical results of potential therapies
- 18:1118:11, 22 May 2015 diff hist +4 m MuSK protein →MuSK's role in disease: Added wiki links
- 18:1018:10, 22 May 2015 diff hist +4 m MuSK protein →MuSK's role in disease: Added preclinical therapy potential
- 18:0918:09, 22 May 2015 diff hist +508 m MuSK protein →MuSK's role in disease: Added preclinical therapy potential
- 18:0418:04, 22 May 2015 diff hist +1 m Nystagmus →Treatment: fixed typo
- 18:0418:04, 22 May 2015 diff hist +439 m Nystagmus →Treatment: added treatment availability
21 May 2015
- 19:3719:37, 21 May 2015 diff hist −1 m Neuromuscular junction →Congenital myasthenic syndromes: fixed capitalization typo
- 19:3419:34, 21 May 2015 diff hist +1,389 m Neuromuscular junction Added CMS treatment information and references
- 19:1819:18, 21 May 2015 diff hist +402 m Neuromuscular junction Added treatment availability information
- 19:1319:13, 21 May 2015 diff hist +3 m Catalyst Pharmaceuticals fixed type
